210 related articles for article (PubMed ID: 19536445)
21. Assessment and treatment selection for "revolving door" inpatients with schizophrenia.
Weiden P; Glazer W
Psychiatr Q; 1997; 68(4):377-92. PubMed ID: 9355136
[TBL] [Abstract][Full Text] [Related]
22. Patterns of care in patients discharged from acute psychiatric inpatient facilities: a national survey in Italy.
Preti A; Rucci P; Gigantesco A; Santone G; Picardi A; Miglio R; de Girolamo G;
Soc Psychiatry Psychiatr Epidemiol; 2009 Sep; 44(9):767-76. PubMed ID: 19212696
[TBL] [Abstract][Full Text] [Related]
23. Psychiatric Hospitalizations of Chronic Psychotic Disorder Patients With and Without Dual Diagnosis, Israel, 1963-2016.
Florentin S; Rosca P; Raskin S; Bdolah-Abram T; Neumark Y
J Dual Diagn; 2019; 15(3):130-139. PubMed ID: 31079564
[No Abstract] [Full Text] [Related]
24. [Use of atypical antipsychotics in Charles Perrens psychiatric hospital (Bordeaux) analysis of prescribing practices for Amisulpride, Clozapine, Olanzapine and Risperidone].
Bret P; Bonnet F; Bret MC; Jaffré A
Encephale; 2002; 28(4):329-42. PubMed ID: 12232542
[TBL] [Abstract][Full Text] [Related]
25. Assessing clinical predictions of early rehospitalization in schizophrenia.
Olfson M; Mechanic D; Boyer CA; Hansell S; Walkup J; Weiden PJ
J Nerv Ment Dis; 1999 Dec; 187(12):721-9. PubMed ID: 10665466
[TBL] [Abstract][Full Text] [Related]
26. Switching antipsychotics in inpatient schizophrenia care: predictors and outcomes.
Weinmann S; Janssen B; Gaebel W
J Clin Psychiatry; 2004 Aug; 65(8):1099-105. PubMed ID: 15323596
[TBL] [Abstract][Full Text] [Related]
27. A naturalistic study of risperidone treatment outcome using prognosis-adjusted discharge rates in New York State inpatients.
Javitt DC; Cienfuegos A; Miniati M; Silipo G; Levine J; Allingham BH; Robinson J
J Clin Psychiatry; 2002 Jul; 63(7):585-90. PubMed ID: 12143914
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of factors influencing medication compliance in inpatient treatment of psychotic disorders.
Janssen B; Gaebel W; Haerter M; Komaharadi F; Lindel B; Weinmann S
Psychopharmacology (Berl); 2006 Aug; 187(2):229-36. PubMed ID: 16710714
[TBL] [Abstract][Full Text] [Related]
29. Psychiatric hospital utilization in patients treated with clozapine for up to 4.5 years in a state mental health care system.
Reid WH; Mason M
J Clin Psychiatry; 1998 Apr; 59(4):189-94. PubMed ID: 9590670
[TBL] [Abstract][Full Text] [Related]
30. Depression during an acute episode of schizophrenia or schizophreniform disorder and its impact on treatment response.
Jäger M; Riedel M; Schmauss M; Pfeiffer H; Laux G; Naber D; Gaebel W; Huff W; Schmidt LG; Heuser I; Buchkremer G; Kühn KU; Rüther E; Hoff P; Gastpar M; Bottlender R; Strauss A; Möller HJ
Psychiatry Res; 2008 Apr; 158(3):297-305. PubMed ID: 18280582
[TBL] [Abstract][Full Text] [Related]
31. Impact of synthetic cannabinoid use on hospital stay in patients with bipolar disorder versus schizophrenia, or other psychotic disorders.
Deng H; Mohite S; Suchting R; Nielsen DA; Okusaga OO
Psychiatry Res; 2018 Mar; 261():248-252. PubMed ID: 29329043
[TBL] [Abstract][Full Text] [Related]
32. Has the attempt to reduce psychiatric inpatient treatment been successful in Finland?
Kaltiala-Heino R; Laippala P; Joukamaa M
Eur Psychiatry; 2001 Jun; 16(4):215-21. PubMed ID: 11418271
[TBL] [Abstract][Full Text] [Related]
33. Relationship between diagnosis and disposition of patients admitted to a state psychiatric hospital.
Advokat C; Eustis N; Pickering J
Psychiatr Q; 2005; 76(2):97-106. PubMed ID: 15884739
[TBL] [Abstract][Full Text] [Related]
34. [French Society for Biological Psychiatry and Neuropsychopharmacology task force: Formal Consensus for the prescription of depot antipsychotics].
Samalin L; Abbar M; Courtet P; Guillaume S; Lancrenon S; Llorca PM
Encephale; 2013 Dec; 39 Suppl 4():189-203. PubMed ID: 24373464
[TBL] [Abstract][Full Text] [Related]
35. [Intervals between hospitalisations in schizophrenia patients under antipsychotics in depot-form versus oral second generation antipsychotics].
Gutwinski S; Müller P; Koller M
Psychiatr Prax; 2007 Sep; 34(6):289-91. PubMed ID: 17806015
[TBL] [Abstract][Full Text] [Related]
36. Predictors of antipsychotic medication change.
Sernyak MJ; Leslie D; Rosenheck R
J Behav Health Serv Res; 2005; 32(1):85-94. PubMed ID: 15632800
[TBL] [Abstract][Full Text] [Related]
37. The association of cannabis use on inpatient psychiatric hospital outcomes.
Rylander M; Winston HR; Medlin H; Hull M; Nussbaum A
Am J Drug Alcohol Abuse; 2018; 44(1):73-84. PubMed ID: 28613973
[TBL] [Abstract][Full Text] [Related]
38. [Relationships between insight and medication adherence in subjects with psychosis].
Droulout T; Liraud F; Verdoux H
Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
[TBL] [Abstract][Full Text] [Related]
39. Reductions in postdischarge suicide after deinstitutionalization and decentralization: a nationwide register study in Finland.
Pirkola S; Sohlman B; Heilä H; Wahlbeck K
Psychiatr Serv; 2007 Feb; 58(2):221-6. PubMed ID: 17287379
[TBL] [Abstract][Full Text] [Related]
40. Practices preventing rehospitalization of individuals with schizophrenia.
Prince JD
J Nerv Ment Dis; 2006 Jun; 194(6):397-403. PubMed ID: 16772855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
